Clinical Trials Directory

Trials / Completed

CompletedNCT02009696

ProMRI Study of the Entovis Pacemaker System (Phase B)

Status
Completed
Phase
Study type
Observational
Enrollment
221 (actual)
Sponsor
Biotronik, Inc. · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The objective of the ProMRI Study (Phase B) is to demonstrate the clinical safety of the ProMRI Pacemaker System when used under specific MRI conditions without scan exclusion zone.

Conditions

Interventions

TypeNameDescription
DEVICEPatients with a ProMRI Pacemaker SystemBradycardia Slow Heart Beat
OTHERMagnetic Resonance Imaging (MRI) scanMRI scan of heart/chest or thoracic spine.

Timeline

Start date
2013-12-01
Primary completion
2014-11-01
Completion
2015-01-01
First posted
2013-12-12
Last updated
2015-11-25
Results posted
2015-07-10

Locations

32 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT02009696. Inclusion in this directory is not an endorsement.

ProMRI Study of the Entovis Pacemaker System (Phase B) (NCT02009696) · Clinical Trials Directory